A Randomized, Double-Blind, Placebo-Controlled Two-Year Trial to Examine the Changes in Exercise Endurance and COPD [chronic obstructive pulmonary disease] Treated With Tiotropium [tiotropium bromide] Once Daily (EXACTT).

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Two-Year Trial to Examine the Changes in Exercise Endurance and COPD [chronic obstructive pulmonary disease] Treated With Tiotropium [tiotropium bromide] Once Daily (EXACTT).

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Oct 2013

At a glance

  • Drugs Tiotropium bromide (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Acronyms EXACTT
  • Most Recent Events

    • 13 Oct 2012 Planned number of patients changed from 519 to 538 as reported by EudraCT.
    • 15 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Feb 2010 Lead trial centre and sponsor (Pfizer) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top